Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology

,

On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further develop a universal vaccine against influenza based on Intravaccメs innovative Outer Membrane Vesicles (OMV) technology. Both parties will collaborate to further advance the candidate vaccine through clinical development.

Tags:


Source: Immune Regulation
Credit: